Arteriovenous malformations in mice lacking activin receptor-like kinase-1

被引:0
|
作者
Lisa D. Urness
Lise K. Sorensen
Dean Y. Li
机构
[1] Program in Human Molecular Biology & Genetics,Department of Medicine
[2] University of Utah,Department of Oncological Sciences
[3] University of Utah,undefined
[4] Howard Hughes Medical Institute,undefined
[5] University of Utah,undefined
[6] University of Utah,undefined
来源
Nature Genetics | 2000年 / 26卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation1,2,3,4. To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-β superfamily of growth factors6,7,8. At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.
引用
收藏
页码:328 / 331
页数:3
相关论文
共 50 条
  • [41] Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
    Oh, SP
    Seki, T
    Goss, KA
    Imamura, T
    Yi, Y
    Donahoe, PK
    Li, L
    Miyazono, K
    ten Dijke, P
    Kim, S
    Li, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2626 - 2631
  • [42] Alk1 (Activin Receptor-Like Kinase 1) and Vascular Hyperpermeability in Diabetic Retinopathy: More Is Less
    Claesson-Welsh, Lena
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (08) : 1673 - 1675
  • [43] Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
    Townson, Sharon A.
    Martinez-Hackert, Erik
    Greppi, Chloe
    Lowden, Patricia
    Sako, Dianne
    Liu, June
    Ucran, Jeffrey A.
    Liharska, Katia
    Underwood, Kathryn W.
    Seehra, Jasbir
    Kumar, Ravindra
    Grinberg, Asya V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (33) : 27313 - 27325
  • [44] Novel Protein Interactions with Endoglin and Activin Receptor-like Kinase 1: Potential Role in Vascular Networks
    Xu, Guoxiong
    Barrios-Rodiles, Miriam
    Jerkic, Mirjana
    Turinsky, Andrei L.
    Nadon, Robert
    Vera, Sonia
    Voulgaraki, Despina
    Wrana, Jeffrey L.
    Toporsian, Mourad
    Letarte, Michelle
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (02) : 489 - 502
  • [45] Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia
    Brusgaard, K
    Kjeldsen, AD
    Poulsen, L
    Moss, H
    Vase, P
    Rasmussen, K
    Kruse, TA
    Horder, M
    CLINICAL GENETICS, 2004, 66 (06) : 556 - 561
  • [46] Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells
    Upton, Paul D.
    Davies, Rachel J.
    Trembath, Richard C.
    Morrell, Nicholas W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (23) : 15794 - 15804
  • [47] Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders
    Katagiri, Takenobu
    Tsukamoto, Sho
    Kuratani, Mai
    BIOMEDICINES, 2021, 9 (07)
  • [48] Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7
    Vestal, Kylie A.
    Kattamuri, Chandramohan
    Koyiloth, Muhasin
    Ongaro, Luisina
    Howard, James A.
    Deaton, Aimee M.
    Ticau, Simina
    Dubey, Aditi
    Bernard, Daniel J.
    Thompson, Thomas B.
    BIOCHEMICAL JOURNAL, 2024, 481 (07) : 547 - 564
  • [49] Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors
    Mansour, Mai A.
    Hassan, Ghaneya S.
    Serya, Rabah A. T.
    Jaballah, Maiy Y.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2024, 147
  • [50] Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues
    Ruan, Xianchun
    Zhang, Zhaowei
    Aili, Munire
    Luo, Xiang
    Wei, Qiang
    Zhang, Demao
    Bai, Mingru
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11